Skip to main content
logo
Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
41.16
-0.55 (-1.32%)
May 7, 2026, 11:13 AM EDT - Market open

Crinetics Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.71.044.014.741.08
Revenue Growth (YoY)
640.71%-74.11%-15.28%339.43%1418.31%
Cost of Revenue
1.08----
Gross Profit
6.621.044.014.741.08
Selling, General & Admin
191.3399.7458.0942.3924.53
Research & Development
332.06240.16168.53130.2384.26
Total Operating Expenses
523.39339.89226.62172.62108.78
Operating Income
-516.77-338.85-222.61-167.88-107.7
Interest Income
51.9941.4413.444.320.16
Other Non-Operating Income (Expense)
-0.36-0.99-5.36-0.35-0.1
Total Non-Operating Income (Expense)
51.6340.9213.284.970.06
Pretax Income
-465.32-297.94-209.33-162.91-107.64
Provision for Income Taxes
0.18----
Net Income
-465.32-298.41-214.53-163.92-107.64
Net Income to Common
-465.32-298.41-214.53-163.92-107.64
Shares Outstanding (Basic)
9481585238
Shares Outstanding (Diluted)
9481585238
Shares Change (YoY)
16.43%39.11%11.71%35.24%26.24%
EPS (Basic)
-4.95-3.69-3.69-3.15-2.80
EPS (Diluted)
-4.95-3.69-3.69-3.15-2.80
Shares Outstanding
95.5792.9368.1853.8847.6
Free Cash Flow
-383.68-234.04-173.29-116.86-89.02
Free Cash Flow Per Share
-4.08-2.90-2.98-2.25-2.32
Gross Margin
86.02%100.00%100.00%100.00%100.00%
Operating Margin
-6714.77%-32613.50%-5547.17%-3544.06%-9990.91%
Profit Margin
-6046.22%-28720.70%-5345.85%-3460.38%-9985.25%
FCF Margin
-4985.50%-22525.30%-4318.12%-2466.98%-8258.26%
EBITDA
-512.88-336.07-221.51-166.9-106.78
EBITDA Margin
-6664.23%-32345.40%-5519.81%-3523.31%-9905.38%
EBIT
-516.77-338.85-222.61-167.88-107.7
EBIT Margin
-6714.77%-32613.50%-5547.17%-3544.06%-9990.91%
Effective Tax Rate
-0.04%0.00%0.00%0.00%0.00%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q